REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children
Launched by SANOFI PASTEUR, A SANOFI COMPANY · Mar 13, 2007
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Healthy child without chronic severe disease of either gender,
- • 2. 6 year-old child on vaccination day,
- • 3. Child previously vaccinated with three doses of a diphtheria, tetanus and poliomyelitis containing vaccine given alone or in combination within the first 6 months of life and a booster dose of a diphtheria, tetanus and poliomyelitis containing vaccine given alone or in combination at 16 - 18 months of life (±2 months),
- • 4. Consent form signed by both parents, or by the legal representative, properly informed about the study.
- Exclusion Criteria:
- • 1. Child who had received less or more than 4 doses of a diphtheria, tetanus and/or poliomyelitis containing vaccine,
- • 2. Previous clinical or bacteriological diagnosis of diphtheria, tetanus or poliomyelitis,
- • 3. Child who had received any vaccine in the previous 30 days or with a vaccination scheduled during the course of the study,
- • 4. Child who present with immune impairment or humoral/cellular deficiency, neoplastic disease or depressed immunity,
- • 5. Child who had received within the previous 150 days or who will receive during the course of the study, any immunoglobulins or blood derived products,
- • 6. Child with true hypersensitivity to at least one of the components of a study vaccine or to streptomycin, neomycin or polymixin B,
- • 7. Known personal history of encephalopathy, seizure disorder or progressive, evolving or unstable neurological condition,
- • 8. Child who had presented severe hypersensitivity following an earlier immunization against diphtheria and/or tetanus,
- • 9. Known history of thrombocytopenia or any coagulation disorder that would contraindicate intramuscular injection,
- • 10. Acute severe febrile illness and/or oral temperature ≥37.5°C at the time of vaccination
About Sanofi Pasteur, A Sanofi Company
Sanofi Pasteur, a subsidiary of Sanofi, is a global leader in the development and production of vaccines. With a rich heritage in vaccine innovation, the company is dedicated to advancing public health by providing safe, effective, and accessible immunizations for a wide range of infectious diseases. Sanofi Pasteur invests significantly in research and development to address evolving health challenges and to enhance vaccine coverage worldwide. Committed to collaboration with health organizations and communities, the company strives to protect individuals and populations through its comprehensive portfolio of vaccines, contributing to the prevention of diseases and the promotion of healthier lives globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Arras, , France
Nancy, , France
Poitiers, , France
Rouen, , France
Brest, , France
Draguignan, , France
Toulouse, , France
Laon, , France
Annecy, , France
Paris, , France
Caen, , France
Strasbourg, , France
Quimper, , France
Albi, , France
Floirac, , France
Le Havre, , France
Maromme, , France
Nogent Sur Marne, , France
Angers, , France
Clamart, , France
Besancon, , France
Albertville, , France
Anzin, , France
Asnieres, , France
Avion, , France
Bassens, , France
Bersee, , France
Blois, , France
Boulogne, , France
Broglie, , France
Chalon En Champagne, , France
Champdeniers, , France
Chigny Les Roses, , France
Cholet, , France
Claix, , France
Collombey Les Belles, , France
Enghien Les Bains, , France
Frouard, , France
Haguenau, , France
Illkirch Graffenstaden, , France
Issy Les Moulineaux, , France
La Neuville Roy, , France
Les Pieux, , France
Louverne, , France
Louvigne De Bais, , France
Manduel, , France
Marcq En Barouel, , France
Marseille, , France
Miniac Morvan, , France
Montpellier, , France
Montsang/Orge, , France
Morangis, , France
Nantes, , France
Ostwald, , France
Plouzane, , France
Pont A Mousson, , France
Saint Sebastien Sur Loir, , France
Saint Ouen, , France
Saint Raphael, , France
Sanary Mer, , France
Sevres, , France
Villemomble, , France
Patients applied
Trial Officials
Medical Director
Study Director
Sanofi Pasteur, a Sanofi Company
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials